Ahead of Memorial Day weekend, Cellcom reaffirms CEO message and shares key service info
(WFRV) – As the Memorial Day weekend begins, Cellcom is reminding customers that the most recent message from its CEO remains the most current and complete source of company updates.
According to a new post from Cellcom's Facebook, the message outlines Cellcom's direction and what the team is actively working toward.
The message shared earlier this week by our CEO remains our most current and comprehensive update. It continues to reflect what we're working toward and where we're headed.
Cellcom CEO addresses outage: 'We experienced a cyber incident'
With the holiday weekend bringing increased demand and possible service questions, the company is encouraging all customers to rely on one source for updates.
To avoid confusion, all future updates and important news will be shared only through Cellcom's official service page: cellcom.com/service.
Customers are encouraged to check the page if they experience service issues or are seeking the latest news from the company over the holiday weekend.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Jim Cramer on Build-A-Bear Workshop (BBW): 'I'm a Holder, Not a Buyer'
We recently published a list of . In this article, we are going to take a look at where Build-A-Bear Workshop, Inc. (NYSE:BBW) stands against other stocks that Jim Cramer discussed recently. A caller asked if they should hold, trim, or add to their position in Build-A-Bear Workshop, Inc. (NYSE:BBW). Cramer replied: 'Alright, I remember many, many years ago when Danny Meyer came here… and he said, listen, this is a company to watch. It is a company that is also a great hospitality company. And I'm going to tell you I have followed it ever since. I cannot believe it had that earnings breakout. And if anything… I'm a holder, not a buyer, because it just had that spike. But if it came down, I would certainly be a buyer.' A smiling woman walking out of a franchised store, her new purchase in her arm. Build-A-Bear Workshop (NYSE:BBW) is a retailer that provides customizable plush toys, pre-stuffed animals, scents, sounds, and a variety of accessories, clothing, and novelty items, with stores operating under the Build-A-Bear Workshop name. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
SoundHound (SOUN) AI Bets Big on Voice: 60% of Revenue Now Tied to Amelia
We recently published a list of . In this article, we are going to take a look at where SoundHound AI, Inc. (NASDAQ:SOUN) stands against other trending AI stocks on Wall Street right now. On June 3rd, Northland analyst Michael Latimore reiterated a Market Perform rating on SoundHound AI, Inc. (NASDAQ:SOUN) with an $8.00 price target. Analysts are optimistic about SoundHound AI's long-term potential, particularly based on its goal to improve human-to-machine interactions and customer experiences. Its acquisition of conversational AI Company Amelia has been particularly helpful in reshaping its revenue profile and accelerating its expansion into the customer and employee service market. A software engineer focused on a computer screen, writing code to create a conversational assistant. 60% of SoundHound's revenue in the first quarter of 2025 is attributable to Amelia, leading to an impressive 101% year-over-year growth. The remaining revenue is estimated to come evenly from the restaurant and automotive sectors. The analysts also highlighted SoundHound's proprietary Voice AI platform, praised for its speed and accuracy in processing complex voice queries. Amelia integrates its software with enterprise IT systems, which helps to facilitate the adoption of virtual agents. Analysts also pointed out that the management is optimistic about the second half of the year, anticipating significant growth backed by large Amelia software license deals and increased activity in the restaurant sector. As such, the company strives to return to pro forma organic growth by the third quarter and achieve positive EBITDA by the end of the year. SoundHound AI, Inc. (NASDAQ:SOUN) is a voice artificial intelligence company offering voice AI solutions to businesses. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
2 hours ago
- Yahoo
HighTide Therapeutics And 2 Other Asian Penny Stocks To Watch Closely
Amidst a backdrop of fluctuating global trade policies and easing inflation, Asian markets have been navigating a complex economic landscape. For investors eyeing opportunities in smaller or newer companies, penny stocks—though an outdated term—still hold potential for growth at accessible price points. These stocks can offer notable value when backed by strong financials, making them intriguing options for those seeking hidden gems with promising long-term prospects. Name Share Price Market Cap Financial Health Rating Halcyon Technology (SET:HTECH) THB2.64 THB792M ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.445 SGD180.35M ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.176 SGD35.06M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.21 SGD8.7B ★★★★★☆ BRC Asia (SGX:BEC) SGD3.13 SGD858.72M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$1.90 HK$3.28B ★★★★★☆ Bosideng International Holdings (SEHK:3998) HK$4.39 HK$50.26B ★★★★★★ Lever Style (SEHK:1346) HK$1.15 HK$725.59M ★★★★★★ Goodbaby International Holdings (SEHK:1086) HK$1.20 HK$2B ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.04 HK$1.7B ★★★★★★ Click here to see the full list of 1,161 stocks from our Asian Penny Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: HighTide Therapeutics, Inc. is a biopharmaceutical company focused on discovering, researching, developing, and commercializing therapies for metabolic and digestive diseases in Mainland China, with a market cap of HK$1.42 billion. Operations: HighTide Therapeutics, Inc. has not reported any specific revenue segments at this time. Market Cap: HK$1.42B HighTide Therapeutics, Inc., a pre-revenue biopharmaceutical company, recently announced positive Phase 3 trial results for its lead compound HTD1801 in treating type 2 diabetes mellitus. Despite its lack of revenue and current unprofitability, the company has a strong financial position with short-term assets exceeding liabilities and more cash than debt. The management team is experienced, although the board is relatively new. HighTide's stock remains highly volatile, reflecting typical penny stock characteristics. The upcoming NDA submission for HTD1801 could be pivotal if approved by China's regulatory authorities later this year. Take a closer look at HighTide Therapeutics' potential here in our financial health report. Gain insights into HighTide Therapeutics' past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Shandong Molong Petroleum Machinery Company Limited, along with its subsidiaries, focuses on the design, research and development, production, and sale of energy equipment products and services both in China and internationally, with a market cap of HK$3.06 billion. Operations: No specific revenue segments are reported for Shandong Molong Petroleum Machinery Company Limited. Market Cap: HK$3.06B Shandong Molong Petroleum Machinery has shown a mix of financial challenges and operational resilience. Despite being unprofitable, the company maintains a positive cash runway for over three years, supported by CN¥2 billion in short-term assets exceeding its liabilities. However, its high net debt to equity ratio of 201.3% and increased debt levels highlight financial strain. The recent earnings report shows improved revenue but a significant drop in net income compared to the previous year, indicating volatility typical of penny stocks. Management's lack of experience could impact strategic decisions as they navigate these complexities. Unlock comprehensive insights into our analysis of Shandong Molong Petroleum Machinery stock in this financial health report. Assess Shandong Molong Petroleum Machinery's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Chongqing Lummy Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and sale of pharmaceutical products in China with a market cap of CN¥3.92 billion. Operations: The company's revenue is primarily generated from its operations in China, amounting to CN¥812.87 million. Market Cap: CN¥3.92B Chongqing Lummy Pharmaceutical faces financial challenges typical of penny stocks, with a net loss of CN¥13.78 million reported for Q1 2025 despite revenue growth to CN¥198.4 million. The company is unprofitable but has improved its debt profile, reducing the debt-to-equity ratio from 74.9% to 18.6% over five years and maintaining more cash than total debt, providing a stable cash runway exceeding three years even if free cash flow declines. Short-term assets of CN¥1.5 billion comfortably cover liabilities, though ongoing losses necessitate careful management by its experienced leadership team averaging over eight years in tenure. Click to explore a detailed breakdown of our findings in Chongqing Lummy Pharmaceutical's financial health report. Review our historical performance report to gain insights into Chongqing Lummy Pharmaceutical's track record. Click this link to deep-dive into the 1,161 companies within our Asian Penny Stocks screener. Looking For Alternative Opportunities? The end of cancer? These 23 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:2511 SEHK:568 and SZSE:300006. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
